Inicio › Cáncer de pulmón › Nebraska
Ensayos clínicos de Cáncer de pulmón en Nebraska
19 estudios sobre Cáncer de pulmón buscan participantes en Nebraska.
Ciudades en Nebraska
Texto oficial del estudio (inglés)
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07063745This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Fremont, Fremont
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island, Grand Island
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Regional, Grand Island
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06758401Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Nebraska Medicine-Bellevue, Bellevue
- Fred and Pamela Buffett Cancer Center - Kearney, Kearney
- CHI Health Good Samaritan, Kearney
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Nebraska Cancer Specialists - Grand Island, Grand Island
- Nebraska Cancer Specialists, Omaha
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- NHO Revive Research Institute, Lincoln
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- y 2 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Cancer Partners of Nebraska, Lincoln
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
- Mary Lanning Healthcare (MLH) - Morrison Cancer Center (MCC), Hastings
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06712316Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Nebraska Cancer Specialists, Omaha
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT06922591Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Omaha
ReclutandoFase 2
Edades de 18 a 95 · Todos los sexos · Actualizado el 21 oct 2026 · NCT05061550Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Nebraska Cancer Specialist, Grand Island
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Nebraska Hematology-Oncology (NHO), Lincoln
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Nebraska Medicine- Bellevue Medical Center, Bellevue
- Cancer Partners of Nebraska, Lincoln
- Nebraska Medicine, Omaha
- y 2 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07489066Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NHO Revive Research Institute, LLC, Lincoln
- NHO Support Center, Lincoln
- Cancer Partners of Nebraska, Lincoln
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222566Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
- Nebraska Methodist Hospital, Omaha
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer
- University of Nebraska Medical Center, Omaha
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05242965Integrated Cancer Repository for Cancer Research
- Mary Lanning Healthcare, Morrison Cancer Center, Hastings
- Faith Regional Health Services, Carson Cancer Center, Norfolk
- Great Plains Regional Medical Center, North Platte
- y 3 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of Nebraska Medical Center, Omaha
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 26 jun 2026 · NCT04614103SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Omaha
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.